Sir -Interest in enhancing the activity of by the use of prolonged infusions and/or modulation with high dose folinic acid continues. Early studies showed an increased response rate and survival benefit in colorectal adenocarcinoma (Erlichman et al., 1988) , but more variable response rates of 12-48% in advanced gastric adenocarcinoma (Machover et al., 1986; Arbuck et al., 1987) . Recently short infusions of high dose folinic acid and 5-FU have produced response rates of 40% and 43.5% (Johnson et al., 1991; Louvet et al., 1991) .
High-dose folinic acid with 5-fluorouracil bolus and continuous infusion in the treatment of advanced gastric and oesophageal adenocarcinoma Sir -Interest in enhancing the activity of by the use of prolonged infusions and/or modulation with high dose folinic acid continues. Early studies showed an increased response rate and survival benefit in colorectal adenocarcinoma (Erlichman et al., 1988) , but more variable response rates of 12-48% in advanced gastric adenocarcinoma (Machover et al., 1986; Arbuck et al., 1987) . Recently short infusions of high dose folinic acid and 5-FU have produced response rates of 40% and 43.5% (Johnson et al., 1991; Louvet et al., 1991) .
We have treated 15 patients with advanced histologically confirmed gastric and oesophageal adenocarcinoma using the regimen described by De Gramont (De Gramont et al., 1988 The treatment regimen consisted of folinic acid 200mg m-2 in 500 ml of N-saline over 2 h followed by 5-FU 400 mg m2 IV bolus then 5-FU 400 mg m-2 in 1000 ml of N-saline over 22 h. This was repeated on day 2. Oral mucositis was limited by the prophylactic use of allopurinol mouthwash, initially hourly for 4 h after the folinic acid infusion, then four hourly. Laser (Johnson et al., 1991) achieved a response rate of 40% (95% CI 10-70%) in advanced gastric cancer. Similarly, Louvet (Louvet et al., 1991) 
